Skip to main content
Premium Trial:

Request an Annual Quote

Shimadzu Obtains ISO 13485 Certification for US LC-MS Manufacturing Facility

Premium

Shimadzu said this week that its US manufacturing subsidiary Shimadzu USA Manufacturing has obtained ISO 13485 certification for the manufacture of its liquid chromatography and mass spectrometry systems.

The certification allows SUM to manufacture these instruments for clinical testing in the US market.

"Mass spectrometry has a growing presence in clinical research and laboratory medicine," Shinichi Matsunaga, president of Shimadzu U.S.A. Manufacturing, said in a statement. "Achieving ISO 13485 certification is a major milestone for Shimadzu and a great step towards developing mass spectrometry platforms as next generation medical devices."

The company added that it will continue to registed medical devices with the US Food and Drug Administration, "and support the growing demand for LC and LC-MS in the clinical testing market."

To date, Shimadzu has not registered any of its LC-MS systems with FDA as class I exempt medical devices, a requirement for their use in clinical applications.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.